All treatments
Treatment
Zimberelimab, Trodelvy 200 mg powder for concentrate for solution for infusion clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
Bladder Preservation with Sacituzumab Govitecan + Zimberelimab for MuscleInvasive Bladder cancer in cisplatin-unfit and unwilling for cystectomy patients: phase II trial (preSAVE trial)
This study looks at new treatments (Zimberelimab and Trodelvy) for muscle-invasive bladder cancer in people who can't have surgery or choose not to. We want to see how well these drugs can help control the cancer and avoid surgery.
For: Muscle-Invasive Bladder cancerItaly - AuthorisedTherapeutic exploratory (Phase II)
A multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer (NeoTRACE) [without IMPD-Q]
This study is for people with a type of lung cancer that can be removed with surgery. It looks at new treatments given before and after surgery to see if they can help shrink the cancer and stop it from coming back.
For: non-small cell lung cancerGermany